Vimarsana
Biggest News Aggregation in the World

Extra Cellular Matrix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Extra Cellular Matrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Extra Cellular Matrix Today - Breaking & Trending Today

BICO : Carcinotech and CELLINK Enter a Partnership to Develop and Commercialize Protocols for Cancer Models to Provide Improved Speed and Accuracy in the Drug Development Processes -October 04, 2023 at 11:43 pm EDT - Vimarsana News

BICO : Carcinotech and CELLINK Enter a Partnership to Develop and Commercialize Protocols for Cancer Models to Provide Improved Speed and Accuracy in the Drug Development Processes -October 04, 2023 at 11:43 pm EDT

Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK's bioprinting solutions and Carcinotech's expertise in producing 3D bioprinted living tumors to...

Preventing and reversing glycation process to counteract gravity constraint - Vimarsana News

Preventing and reversing glycation process to counteract gravity constraint

Science has definitely shown and convinced consumers of the pro-ageing action of our exposome. Sun exposure, pollution, tobacco but also lifestyle are directly affecting skin structure and youth. Among all these factors, gravity remains a parameter that cannot be avoided and mastered. With ageing, skin less firm and subject to the effects of gravity, stretches without being able to retract; accentuating the depth of wrinkles. Bioinspired by Isodon japonicus and its ability to stand upright...

Nordic Bioscience and Roche Diagnostics Strengthen Collaboration for Development of Biomarkers for Chronic Diseases - Vimarsana News

Nordic Bioscience and Roche Diagnostics Strengthen Collaboration for Development of Biomarkers for Chronic Diseases

/PRNewswire/ -- Nordic Bioscience, a growing biomarker company, today announced the strengthening of its ongoing collaboration with Roche Diagnostics for the...

HCS Pharma Secures 20 Million EUR Capital Commitment from the GEM Group for the Development of BIOMIMESYS速 Products - Vimarsana News

HCS Pharma Secures 20 Million EUR Capital Commitment from the GEM Group for the Development of BIOMIMESYS速 Products

HCS Pharma Secures 20 Million EUR Capital Commitment from the GEM Group for the Development of BIOMIMESYS® Products HCS Pharma announced today that it has signed an agreement with GEM Global Yield LLC SCS ("GEM") a Luxemburg-based private alternative investment group for a EUR 20 million capital commitment. Loos, France, August 04, 2021 --(PR.com)-- Under the agreement, GEM commits to provide HCS Pharma with a share subscription facility of up to EUR 20 million for a 36-month term following the public listing of the company shares on a European National Stock Exchange. HCS Pharma will contr...

Source: pr.com